Newsletter Subject

Kate Middleton Has Cancer

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Mar 23, 2024 11:14 AM

Email Preheader Text

Weekly Review Saturday, March 23, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, March 23, 2024 [Kate Middleton Has Cancer]( [Elon Musk's Ketamine Use]( [How Often Should Immunocompromised People Get a COVID Booster?]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [Hold Your Horses, Health Workers With COVID Still Must Isolate]( ['Status Credentialus': The Case Against the Misery That Is Medical Credentialing]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT ['It's Much More Severe, and It's Much More Dangerous': What We Heard This Week]( CME SPOTLIGHT [Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches]( [Novel Oral Antihypertensive Gets FDA's Blessing]( ['Foot Bath' Fraud; Doc's Wrongful Termination Suit; Nurse Overdosed Patients?]( [Early Stroke Scare With Bivalent COVID Vaccines Unsupported by Large Study]( CME SPOTLIGHT [Expert Insights and System-Based Care Trends in Early-Stage NSCLC and Melanoma, Metastatic Bladder Cancer, and Relapsed/Refractory Follicular Lymphoma]( [Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients]( [Can You Buy Your Way Into Residency?]( [Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [Who Really 'Died Suddenly'? Anabolic Steroid Users.]( [A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?]( [Can an Autoimmunity Lead to Immune Deficiency?]( CME SPOTLIGHT [Leveraging the Multidisciplinary Team to Improve Lung Cancer Care]( [First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps]( [Acute Kidney Injury: The Price of Straight Hair?]( [Alcohol-Associated Cirrhosis and Death Are on the Rise: Here's How We Can Help]( CME SPOTLIGHT [PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer]( [Havana Syndrome Mystery Continues to Deepen]( [Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs]( [Psilocybin for Depression Win; 1 in 10 Kids Have ADHD; Loneliness in Middle Age]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [Delta-8 THC Use Common in Teens; New Drug-Coated Balloon for Blocked Stents]( [The Power of Saying 'No' in Medicine]( [Skin Test Detects Parkinson's and Other Synucleinopathies]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [Structural Heart Metrics Debut; Amenorrhea-CVD Link; Once-a-Day Antianginal?]( [Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules]( [New Monoclonal Authorized to Prevent COVID in Immunocompromised People]( [Are Your Patients' Allergies Worsening? Climate Change May Be at Play]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-03-23&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

01/06/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

30/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.